Global Medical REIT Inc. (NYSE:XRN – Get Free Report) CEO Mark Okey Decker, Jr. purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were acquired at an average price of $33.94 per share, for a total transaction of $169,700.00. Following the purchase, the chief executive officer owned 59,774 shares in the company, valued at $2,028,729.56. The trade was a 9.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Global Medical REIT Stock Performance
Shares of XRN opened at $34.11 on Wednesday. The company’s fifty day moving average is $35.04 and its 200-day moving average is $34.44. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The firm has a market cap of $451.21 million, a price-to-earnings ratio of -30.73 and a beta of 1.11. The company has a quick ratio of 0.61, a current ratio of 0.68 and a debt-to-equity ratio of 1.68.
Global Medical REIT Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Friday, September 18th. Investors of record on Thursday, August 20th will be paid a $0.16 dividend. The ex-dividend date is Thursday, August 20th. This represents a c) dividend on an annualized basis and a yield of 5.6%. Global Medical REIT’s dividend payout ratio (DPR) is presently -270.27%.
Hedge Funds Weigh In On Global Medical REIT
Analyst Upgrades and Downgrades
XRN has been the topic of a number of research analyst reports. Compass Point reiterated a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th. Wall Street Zen downgraded shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday. Finally, Weiss Ratings downgraded shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.67.
Check Out Our Latest Research Report on XRN
About Global Medical REIT
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
Read More
- Five stocks we like better than Global Medical REIT
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
